During the eight-week treatment phase, patients received either moxonidine (0.2 or 0.4 mg/day) or the ACE inhibitor ramipril (2.5 or 5 mg/day). Conclusions: Moxonidine and ramipril exhibited ...

The update pertains to three types of Ramipril 2.5 mg capsules: However, a letter written by The California State Board of Pharmacy indicates that an additional 8 lots of Ramipril Capsules USP 5 ...